Feed/Companies/LifeMine

LifeMine

As of 14 Oct 2026, LifeMine has raised $188M across 1 verified round on record; latest: $188 million Series E led by Milky Way Investments, announced 6 Aug 2026.

BUILT ON

Visit site

LifeMine is a clinical-stage biopharmaceutical company that develops next-generation precision medicines through an innovative drug discovery approach focused on evolutionary insights from fungi, targeting patients in need of breakthrough therapies.

lifeminetx.comWatertown, MassachusettsBiotech

LATEST ROUND

Series E

$188M · 2026-08-06

RAISED ON RECORD · USD

$188M

1 verified round · $263M to date, as reported

INVESTORS

1 lead

SOURCES

from 1 publisher

Rounds

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Series E

$188M · 2026-08-06

[ HISTORY ]

led by Milky Way Investments

Round	Amount	Announced	Lead	Buzz
Series E [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$188M $263M to date	2026-08-06	Milky Way Investments	No recent discussion
1 source [ VERIFIED ] read against 1 source The article's $263 million figure combines the Series E with a previously completed Series D; it is not the Series E's amount. Published by hand (mgmtboston.com): "The total comprises an oversubscribed $188 million Series E led by Milky Way Investments.": biggest-rounds completeness (K): the round's own page (company, lead investor or trade press) states it

LifeMine

Rounds

Company

Rounds

Sources

Profile

Investors

LifeMine

Rounds

Profile

Sources

Series E$188M2026-08-061 source

Investors

Series E$188M2026-08-069 investors